Inhibitor incidence in previously untreated patients (PUPs) with hemophilia A and B. A prospective multi-center study of the Pediatric Committee of the German, Swiss and Austrian Society for Thrombosis and Hemostasis Research (GTH)

被引：5

作者：

Kreuz, W ^{[1
]}

Auerswald, G ^{[1
]}

Budde, U ^{[1
]}

Klose, HJ ^{[1
]}

Lenk, H ^{[1
]}

机构：

[1] Klinikum Johann Wolfgang Goethe Univ, Klin Kinderheilkunde 3, Frankfurt, Germany

来源：

35TH HEMOPHILIA SYMPOSIUM | 2006年

关键词：

D O I：

10.1007/3-540-28546-6_6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：34 / +

页数：2

共 4 条

[1] Inhibitor development in previously untreated patients with hemophilia A: A prospective long-term follow-up comparing plasma-derived and recombinant products [J].

Kreuz, W ;

Ettingshausen, CE ;

Zyschka, A ;

Oldenburg, J ;

Saguer, IM ;

Ehrenforth, S ;

Klingebiel, T .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (03) :285-290

[2] Incidence of factor VIII inhibitors in severe haemophilia:: the importance of patient age [J].

Lorenzo, JI ;

López, A ;

Altisent, C ;

Aznar, JA .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) :600-603

[3] Environmental and genetic factors influencing inhibitor development [J].

Oldenburg, J ;

Schröder, J ;

Brackmann, HH ;

Müller-Reible, C ;

Schwaab, R ;

Tuddenham, E .

SEMINARS IN HEMATOLOGY, 2004, 41 (01) :82-88

[4]

van der Bom JG, 2003, THROMB HAEMOSTASIS, V89, P475

← 1 →